SAVA (Cassava Sciences Inc) Yalpi foyda bo'yicha sotuv rentabelligi

Cassava Sciences Inc (SAVA) kompaniyasining rasmiy ramzlari

Cassava Sciences, Inc. (SAVA) klinik dasturlarini diversifikatsiya qilish orqali tartibga soluvchi o'zgarishlar xavfini yumshatgan holda, Altsgeymer kasalligi uchun davolash usullarini ishlab chiqmoqda. Biznesning qiymati sug'urta jamg'armalariga kelgusida simufilam sotilishiga asoslanadi. GURU.Markets platformasidagi ushbu yalpi foyda grafigi 0.00 ni oxirgi daraja qiymati sifatida ko'rsatmoqda. Biroq, haddan tashqari yuqori operatsion risklar va testlarning haqiqiyligi bo'yicha bahslar rahbariyatga jiddiy bosim o'tkazmoqda.

Yalpi rentabellik: Cassava Sciences Inc (SAVA) 04.07.2022 - 11.03.2026 uchun

Cassava Sciences Inc (SAVA) moliyaviy va bozor koʻrsatkichlari kesimi

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:SAVA - Cassava
Cassava Sciences asosiy tovari

Noyob Altsgeymer terapiyasi molekulasi uchun patent himoyasi tartibga soluvchi o'zgarishlar bosimiga qaramay Cassava Sciences, Inc. (SAVA) kompaniyasiga uzoq muddatli salohiyatni taqdim etadi. Valoviy marja ulushini tahlil qilish orqali investor bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi qolgan daromadni ko'rishi mumkin, bu esa mavsumiy xarajatlar tebranishlarini samaradorlikning tizimli pasayishidan ajratish imkonini beradi. Ushbu ko'rsatkich operatsion daromadlilikni o'lchaydi va kompaniyaning ma'muriy xarajatlarni qoplash uchun foyda keltirish hamda adolatli qiymatni baholash imkoniyatini belgilaydi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)